Insider · CIK 0001473930

Foley Todd

Reports to the SEC for 22 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001473930

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-12	AKTSAktis Oncology, Inc.C Conversion	Director, 10% Owner	CConversion	+717K sh	—	—	4,002,533
2026-01-12	AKTSAktis Oncology, Inc.P Purchase	Director, 10% Owner	PPurchase	+233K sh	$18.00	+$4.19M	4,235,403
2026-01-12	AKTSAktis Oncology, Inc. · Series A Redeemable Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−10.2M sh	—	—	0
2026-01-12	AKTSAktis Oncology, Inc.C Conversion	Director, 10% Owner	CConversion	+597K sh	—	—	597,391
2026-01-12	AKTSAktis Oncology, Inc.C Conversion	Director, 10% Owner	CConversion	+2.69M sh	—	—	3,285,661
2026-01-12	AKTSAktis Oncology, Inc. · Series B Redeemable Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−2.73M sh	—	—	0
2026-01-12	AKTSAktis Oncology, Inc. · Series Seed Redeemable Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−2.27M sh	—	—	0
2023-06-08	RPTXRepare Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+27.2K sh	—	—	27,200
2022-06-02	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	10% Owner	AAward	+11.9K sh	—	—	11,918
2022-05-13	RPTXRepare Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+49K sh	—	—	49,000
2021-11-02	TRDAEntrada Therapeutics, Inc.C Conversion	10% Owner	CConversion	+509K sh	—	—	4,325,784
2021-11-02	TRDAEntrada Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+100K sh	$20.00	+$2M	4,425,784
2021-11-02	TRDAEntrada Therapeutics, Inc. · Series A Preferred StockC Conversion	10% Owner	CConversion	−27.6M sh	—	—	0
2021-11-02	TRDAEntrada Therapeutics, Inc.C Conversion	10% Owner	CConversion	+3.82M sh	—	—	3,816,760
2021-11-02	TRDAEntrada Therapeutics, Inc. · Series B Preferred StockC Conversion	10% Owner	CConversion	−3.68M sh	—	—	0
2021-10-28	TRDAEntrada Therapeutics, Inc. · Stock Option (Right to Buy)A Award	10% Owner	AAward	+23.6K sh	—	—	23,552
2021-08-05	CHIASMA, INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13K sh	—	—	0
2021-08-05	CHIASMA, INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13K sh	—	—	0
2021-08-05	CHIASMA, INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13K sh	—	—	0
2021-08-05	CHIASMA, INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13K sh	—	—	0
2021-08-05	CHIASMA, INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2021-07-12	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−313 sh	$34.10	−$10.7K	2,242,636
2021-07-12	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−25.2K sh	$33.58	−$848K	2,242,949
2021-07-09	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−1,792 sh	$33.06	−$59.2K	2,268,195
2021-06-29	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−1,190 sh	$33.29	−$39.6K	2,269,987
2021-06-28	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−1,190 sh	$34.82	−$41.4K	2,271,177
2021-06-28	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−6,080 sh	$34.06	−$207K	2,272,367
2021-06-25	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−9,943 sh	$33.51	−$333K	2,278,447
2021-06-24	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−2,697 sh	$33.53	−$90.4K	2,288,390
2021-06-23	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−622 sh	$32.98	−$20.5K	2,291,087
2021-06-22	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−1,486 sh	$33.36	−$49.6K	2,291,898
2021-06-22	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−189 sh	$34.09	−$6,443.01	2,291,709
2021-06-21	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−2,556 sh	$33.80	−$86.4K	2,307,390
2021-06-21	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−14K sh	$34.63	−$485K	2,293,384
2021-06-18	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−1,410 sh	$34.03	−$48K	2,309,946
2021-06-18	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−2,556 sh	$33.46	−$85.5K	2,311,356
2021-06-17	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−753 sh	$34.12	−$25.7K	2,313,912
2021-06-17	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−13.6K sh	$33.78	−$459K	2,314,665
2021-06-16	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−1,862 sh	$33.33	−$62.1K	2,328,240
2021-06-14	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−881 sh	$33.09	−$29.2K	2,330,102
2021-06-09	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−10.7K sh	$34.79	−$374K	2,330,983
2021-06-09	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−4,785 sh	$34.42	−$165K	2,341,721
2021-06-08	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−7,559 sh	$33.41	−$253K	2,346,506
2021-06-08	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−3,985 sh	$32.80	−$131K	2,354,065
2021-06-07	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−8,379 sh	$32.96	−$276K	2,358,050
2021-06-07	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−1,058 sh	$30.74	−$32.5K	2,367,178
2021-06-07	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−749 sh	$32.25	−$24.2K	2,366,429
2021-06-04	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−2,068 sh	$31.28	−$64.7K	2,368,236
2021-06-04	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−3,544 sh	$30.80	−$109K	2,370,304
2021-06-03	RPTXRepare Therapeutics Inc.S Sale	Director	SSale	−9,824 sh	$31.92	−$314K	2,373,848

Recent filings

Accepted (ET)
Jan 144
Foley Todd0001473930-26-000005
SEC(opens sec.gov)
Jun 124
Foley Todd0001209191-23-036304
SEC(opens sec.gov)
Jun 64
Foley Todd0001104659-22-068518
SEC(opens sec.gov)
May 164
Foley Todd0001209191-22-029366
SEC(opens sec.gov)
Nov 44
Foley Todd0001209191-21-062981
SEC(opens sec.gov)
Nov 14
Foley Todd0001209191-21-062225
SEC(opens sec.gov)
Aug 54
Foley Todd0001209191-21-050016
SEC(opens sec.gov)

Address

C/O MPM BIOIMPACT 399 BOYLSTON STREET, SUITE 1100

BOSTON, MA, 02116